Assignee
ZORA BIOSCIENCES OY
FI·22 granted patents·12 pending applications·15 citations·filing 2007–2025
Top patents by PatentIndex Score
34 records- 0189US12025623B2Lipidomic biomarkers for atherosclerosis and cardiovascular diseaseZORA BIOSCIENCES OY·Filed 2019·Granted Jul 2, 2024·2 cites·23 claims
- 0289US9347960B2Ceramides and their use in diagnosing CVDZORA BIOSCIENCES OY·Filed 2015·Granted May 24, 2016·3 cites·35 claims
- 0388US2024385201A1Lipidomic biomarkers for atherosclerosis and cardiovascular diseaseZORA BIOSCIENCES OY·Filed 2024·Application pending·0 cites
- 0488US2024183866A1Ceramides and their use in diagnosing cvdZORA BIOSCIENCES OY·Filed 2024·Application pending·0 cites
- 0587US10197582B2Ceramides and their use in diagnosing CVDZORA BIOSCIENCES OY·Filed 2016·Granted Feb 5, 2019·2 cites·14 claims
- 0687US2026086103A1Biomarkers for cardiovascular eventsZORA BIOSCIENCES OY·Filed 2025·Application pending·0 cites
- 0782US2025355006A1Biomarkers for cardiovascular eventsZORA BIOSCIENCES OY·Filed 2025·Application pending·0 cites
- 0881US11940453B2Ceramides and their use in diagnosing CVDZORA BIOSCIENCES OY·Filed 2022·Granted Mar 26, 2024·0 cites·18 claims
- 0981US10551394B2Lipidomic biomarkers for atherosclerosis and cardiovascular diseaseZORA BIOSCIENCES OY·Filed 2017·Granted Feb 4, 2020·2 cites·26 claims
- 1075US12270816B2Lipidomic biomarkers for identification of high-risk coronary artery disease patientsZORA BIOSCIENCES OY·Filed 2021·Granted Apr 8, 2025·0 cites·14 claims
- 1171US11474116B2Ceramides and their use in diagnosing CVDZORA BIOSCIENCES OY·Filed 2018·Granted Oct 18, 2022·0 cites·11 claims
- 1271US10955427B2Lipidomic biomarkers for identification of high-risk coronary artery disease patientsZORA BIOSCIENCES OY·Filed 2019·Granted Mar 23, 2021·0 cites·30 claims
- 1371US2025264481A1Methods for prediction and early detection of diabetesZORA BIOSCIENCES OY·Filed 2025·Application pending·0 cites
- 1470US12399188B2Biomarkers for cardiovascular eventsZORA BIOSCIENCES OY·Filed 2019·Granted Aug 26, 2025·0 cites·17 claims
- 1569US9052328B2Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatmentZORA BIOSCIENCES OY·Filed 2012·Granted Jun 9, 2015·1 cites·15 claims
- 1669US9052327B2Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatmentZORA BIOSCIENCES OY·Filed 2012·Granted Jun 9, 2015·1 cites·15 claims
- 1766US10534001B2Methods for detecting ovarian cancerZORA BIOSCIENCES OY·Filed 2015·Granted Jan 14, 2020·1 cites·36 claims
- 1861US9863965B2Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatmentZORA BIOSCIENCES OY·Filed 2016·Granted Jan 9, 2018·0 cites·30 claims
- 1960US10261101B2Lipidomic biomarkers for identification of high-risk coronary artery disease patientsZORA BIOSCIENCES OY·Filed 2017·Granted Apr 16, 2019·0 cites·21 claims
- 2059US9857386B2Lipidomic biomarkers for atherosclerosis and cardiovascular diseaseZORA BIOSCIENCES OY·Filed 2016·Granted Jan 2, 2018·0 cites·25 claims
- 2159US9423406B2Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatmentZORA BIOSCIENCES OY·Filed 2015·Granted Aug 23, 2016·0 cites·18 claims
- 2258US12313634B2Methods for prediction and early detection of diabetesZORA BIOSCIENCES OY·Filed 2018·Granted May 27, 2025·0 cites·17 claims
- 2357US2019086386A1USE OF CERAMIDES AND LPLs IN DIAGNOSING CVDZORA BIOSCIENCES OY·Filed 2018·Application pending·0 cites
- 2455US9841431B2Lipidomic biomarkers for identification of high-risk coronary artery disease patientsZORA BIOSCIENCES OY·Filed 2015·Granted Dec 12, 2017·0 cites·22 claims
- 2555US2017082644A1Biomarkers for sensitive detection of statin-induced muscle toxicityZORA BIOSCIENCES OY·Filed 2016·Application pending·0 cites
- 2654US9459264B2Lipidomic biomarkers for atherosclerosis and cardiovascular diseaseZORA BIOSCIENCES OY·Filed 2015·Granted Oct 4, 2016·0 cites·29 claims
- 2753US7611902B2Diagnostic method for myopathyZORA BIOSCIENCES OY·Filed 2007·Granted Nov 3, 2009·3 cites·11 claims
- 2852US10184932B2Use of ceramides and LPLs in diagnosing CVDZORA BIOSCIENCES OY·Filed 2016·Granted Jan 22, 2019·0 cites·3 claims
- 2950US9459265B2Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatmentZORA BIOSCIENCES OY·Filed 2015·Granted Oct 4, 2016·0 cites·21 claims
- 3050US2016363602A1Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatmentZORA BIOSCIENCES OY·Filed 2016·Application pending·0 cites
- 3148US2016018423A1Non-high density lipoprotein derived cvd markersZORA BIOSCIENCES OY·Filed 2014·Application pending·0 cites
- 3247US2016146842A2Sensitive Efficacy and Specificity Biomarkers for Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) InhibitionZORA BIOSCIENCES OY·Filed 2013·Application pending·0 cites
- 3338US2021405054A1Methods for detecting ovarian cancerZORA BIOSCIENCES OY·Filed 2018·Application pending·0 cites
- 3430US2009318392A1Biofluid metabolite profiling as a tool for early prediction of autoimmunity and type 1 diabetes riskZORA BIOSCIENCES OY·Filed 2007·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →